J.Molner AS: J. Molner AS Announces Licensing Agreement for Generic Injectable Drugs with Juno Pharmaceuticals in Canada

Tallinn, 2023-04-06 08:30 CEST --
J. Molner AS, an Estonia-based pharmaceutical company specializing in the
development of innovative generic drugs, announces that it has entered into a
licensing agreement

Related Keywords

Tallinn ,Harjumaa ,Estonia ,Canada ,Toronto ,Ontario ,United States ,Canadian ,Jason Grenfell Gardner ,Jason Grenfell Gardnerj Molner ,Juno Pharmaceuticals ,Health Canada ,Mark Mantel ,Canadian Healthcare ,Molner ,Nnounces ,Icensing ,Agreement ,Generic ,Injectable ,Drugs ,Puno ,Pharmaceuticals ,